Send Email
Send SMS
Search


Anticancer Injection

Our range of products include mozifor 24 mg, cytaneon 100mg injection, cabazitaxel injection, carmustine injection, vidaza injection and intacept 50.

Mozifor 24 mg

REQUEST CALLBACK

Mozifor 24 mg
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 65,000 / VialGet Latest Price

Product Details:
Minimum Order Quantity1 Vial
Usage/ApplicationAutologous stem cell transplant
Anti Cancer Medicine TypeInjection
CompositionPlerixafor
Drug NamePlerixafor
UsageHospital
Packaging TypeVial
Packaging Size1.2ml
Form of MedicineInjection
BrandMozifor
Dose/Strength24mg
CertificationFDA

Mozifor 24 mg Injection is used in Autologous stem cell transplant. It is a procedure in which certain blood cells are removed from the body and then returned to the body after chemotherapy and/or radiation in patients with certain cancers.
Yes! I am Interested

Cytaneon 100Mg Injection

REQUEST CALLBACK

Cytaneon 100Mg Injection
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 83 / VialGet Latest Price

Product Details:
Minimum Order Quantity100 Vial
Manufactured ByNeon Laboratories ltd
BrandCytaneon 100Mg
Packaging Typeglass bottle
Product Typeinjection
CompositionCytarabine
Drug NameCytarabine
SaltCytarabine
Dose Strength100mg
Generic NameCytarabine

Our Specialities Medicines Distribution Organization Is Widely Supplier Of Cytarabin 100Mg Having Brand Name Cytaneon 100Mg Injection Available In 1X10Vial Packing, Manufactured By Neon Laboratories Limited. It Is Stored Below Room Temperature 30°C, Protected From Light. It Is Schedule H Drug, To Be Sold By Retail On The Prescription Of Registered Medical Practitioner Only. ("Take Dose As Directed By The Physician.")
Yes! I am Interested

Cabazitaxel Injection

REQUEST CALLBACK

Cabazitaxel Injection
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 5,000 / VialGet Latest Price

Product Details:
Minimum Order Quantity3 Vial
BrandCabazitaxel
Packaging Typeglass vial
Usage/Applicationchemotherapy
Product Typeinjection
CompositionCabazitaxel
Drug NameCabazitaxel
SaltCabazitaxel
Dose Strength60mg
Generic NameCabazitaxel

Cabazither Cabazitaxel injection is given together with a steroid medicine (eg, prednisone) to treat men with metastatic (cancer that has already spread) prostate cancer. It is used in patients who have already been treated with other medicines that did not work well. Cabazitaxel belongs to the group of medicines called antineoplastics (cancer medicines). It interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected, other unwanted effects will also occur. Some of these may be serious and must be reported to your doctor. This medicine is to be given only by or under the immediate supervision of your doctor.
Yes! I am Interested

Carmustine Injection

REQUEST CALLBACK

Carmustine Injection
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 3,000 / VialGet Latest Price

Product Details:
Minimum Order Quantity3 Vial
BrandCarmustine
Packaging Typeglass vial
Product Typeinjection
CompositionCarmustine
Drug NameCarmustine
SaltCarmustine
Dose Strength100mg
CategoryBrain Tumor
Generic NameCarmustine

Carmustine is used as an alkylating agent to treat several types of brain cancer including glioma, glioblastoma multiforme, medulloblastoma, and astrocytoma), multiple myeloma, and lymphoma (Hodgkin's and non-Hodgkin).
BCNU is sometimes used in conjunction with alkyl guanine transferase (AGT) inhibitors, such as O6-benzylguanine. The AGT-inhibitors increase the efficacy of carmustine by inhibiting the direct reversal pathway of DNA repair, which will prevent the formation of the interstrand crosslink between the N1 of guanine and the N3 of cytosine.
It is also used as part of a chemotherapeutic protocol in preparation for hematological stem cell transplantation, a type of bone marrow transplant, in order to reduce the white blood cell count in the recipient.[2] Use under this protocol, usually with fludarabine and melphalan, was developed by oncologists at the University of Texas MD Anderson Cancer Center.
Yes! I am Interested

Vidaza Injection

REQUEST CALLBACK

Vidaza Injection
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 8,000 / VialGet Latest Price

Product Details:
Minimum Order Quantity1 Vial
BrandAzacitidine
Packaging Typeglass Vial
Usage/Applicationmyelodysplastic syndrome
Product TypeInjection
CompositionAzacitidine
Drug NameAzacitidine
SaltAzacitidine
Dose/Strength100mg
Dosage Forminjection

Vidaza (azacitidine) is an anti-neoplastic pyrimidine nucleoside analog used to treat several subtypes myelodysplastic syndrome, diseases caused by abnormalities in the blood-forming cells of the bone marrow which result in underproduction of healthy blood cells.

Vidaza is specifically indicated for the treatment of the following myelodysplastic syndrome subtypes:

  • Refractory anemia
  • Refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions)
  • Refractory anemia with excess blasts
  • Refractory anemia with excess blasts in transformation
  • Chronic myelomonocytic leukemia

Vidaza is administered via subcutaneous injection, with a starting dosing regimen of 75 mg/m2 daily for seven days, every four weeks. The dose may be increased to 100 mg/m2 if the initial dose is insufficient and toxicity was manageable.

Yes! I am Interested

Intacept 50

REQUEST CALLBACK

Intacept 50
  • Intacept 50
  • Intacept 50
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 5,700 / PieceGet Latest Price

Product Details:
Minimum Order Quantity3 Piece
Product TypeFinished Product
Dose25mg,50mg
Packaging Size1ml
BrandIntas,Cipla
UsagePersonal
CertificationFDA
Form of MedicineInjection
Storagecool

Intacept 50 mg Injection is used in the treatment of ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis and Crohn’s disease.
Yes! I am Interested

Pemmet

REQUEST CALLBACK

Pemmet
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 25,000 / BottleGet Latest Price

Product Details:
Minimum Order Quantity3 Bottle
Injectable FormLiquid
Dose100mg,500mg
Packaging Size100mg,500mg
Usage/ApplicationPersonal
GenderUnisex
Packing Typeinjection
Forminjection
CompositionPemetrexed
Grademedicine
Shelf Lifelong
MaterialPemetrexed
Other NamePemetrexed
Drug Strength500mg
Product TypeFinished Product

Pemmet 500 mg Injection is an anticancer agent which is used in the treatment of lung cancer. It should be used under the supervision of a qualified professional. Close monitoring of kidney function and blood cell count is necessary while receiving this medication.


Additional Information:

  • Delivery Time: Depend on distance
  • Yes! I am Interested

    Bendit 100mg

    REQUEST CALLBACK

    Bendit 100mg
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 3,800 / BottleGet Latest Price

    Product Details:
    Minimum Order Quantity3 Bottle
    Dose/Strength100mg
    Packaging TypeBottle
    BrandBendit 100mg
    Dosage FormInjection
    CompositionBendamustine
    Drug NameBendamustine

    Bendit Injection is a nitrogen-mustard compound used in the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.

    Additional Information:

  • Delivery Time: Depend on Distance
  • Yes! I am Interested

    Halaven Injection

    REQUEST CALLBACK

    Halaven Injection
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 26,000 / VialGet Latest Price

    Product Details:
    Minimum Order Quantity3 Vial
    BrandEsai
    Strength0.88mg
    Product TypeVial
    Dose/Strength0.88mg
    Packaging TypeFinished product
    CertificationFDA, ISO, GMP
    Dosage FormInjection
    Grade Standardmedicine
    Packing Materialglass
    Storage Conditioncool Place
    GenderUnisex
    Form of MedicineInjection
    No of tabletsno
    Manufactured ByEsai
    Compositioneribuline
    Drug Nameeribuline
    Salteribuline
    Expiry Datelong
    Usage/Applicationpersonal

    HALAVEN is a prescription medicine used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other types of anticancer medicines after the cancer has spread.

    HALAVEN can cause serious side effects, including

    • Low white blood cell count (neutropenia). This can lead to serious infections that could lead to death. Your health care provider will check your blood cell counts. Call your health care provider right away if you develop fever (temperature above 100.5°F), chills, cough, or burning or pain when you urinate, as any of these can be symptoms of infection
    • Numbness, tingling, or pain in your hands or feet (peripheral neuropathy). Peripheral neuropathy is common with HALAVEN and sometimes can be severe. Tell your health care provider if you have new or worsening symptoms of peripheral neuropathy
    • Your health care provider may delay or decrease your dose or stop treatment with HALAVEN if you have side effects

    Before you receive HALAVEN, tell your health care provider about all of your medical conditions, including if you

    • have liver or kidney problems
    • have heart problems, including a problem called congenital long QT syndrome
    • have low potassium or low magnesium in your blood
    • are pregnant or plan to become pregnant. HALAVEN can harm your unborn baby. Tell your health care provider right away if you become pregnant or think you are pregnant during treatment with HALAVEN. Females who are able to become pregnant should use an effective form of birth control during treatment with HALAVEN and for at least 2 weeks after the final dose of HALAVEN and males should use an effective form of birth control when having sex with female partners who are able to become pregnant during treatment with HALAVEN and for 3½ months (14 weeks) after the final dose of HALAVEN
    • are breastfeeding or plan to breastfeed. It is not known if HALAVEN passes into your breast milk. Do not breastfeed during treatment with HALAVEN and for 2 weeks after the final dose of HALAVEN

    Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

    What are the possible side effects of HALAVEN?

    HALAVEN can cause changes in your heartbeat (called QT prolongation). This can cause irregular heartbeats. Your health care provider may do heart monitoring (electrocardiogram or ECG) or blood tests during your treatment with HALAVEN to check for heart problems.

    The most common side effects of HALAVEN in adults with breast cancer include low white blood cell count (neutropenia), low red blood cell count (anemia), weakness or tiredness, hair loss (alopecia), nausea, and constipation.

    Your health care provider will do blood tests before and during treatment while you are taking HALAVEN.

    Yes! I am Interested

    Cyramza Ramucirumab

    REQUEST CALLBACK

    Cyramza Ramucirumab
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 1.6 Lakh / VialGet Latest Price

    Product Details:
    Minimum Order Quantity1 Vial
    Dose/Strength500mg/50ml 100mg/10ml
    Packaging Typeinjection
    UsagePersonal
    CertificationGMP, FDA, ISO
    Dosage Form500mg,100mg
    GenderUnisex
    Form of Medicineinjection
    Other NameRamucirumab
    CompositionRamucirumab
    Drug NameRamucirumab
    SaltRamucirumab

    Ramucirumab is a fully human monoclonal antibody developed for the treatment of solid tumors. This drug was developed by ImClone Systems Inc. It was isolated from a native phage display library from Dyax.

    Chemocare.com uses generic names in all descriptions of drugs. Ramucirumab is the generic name for CYRAMZA™. In some cases, health care professionals may use the generic name ramucirumab when referring to the trade drug name CYRAMZA™.

    Drug type: Ramucirumab is a monoclonal antibody, Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Inhibitor. (For more detail, see "How this drug works" section below).

    • Treatment of advanced gastric cancer or gastro-esophageal junction adenocarcinoma.
    • Non-small cell Lung cancer
    • Metastatic Colorectal cancer

     

    Note: If a drug has been approved for one use, physicians sometimes elect to use this same drug for other problems if they believe it might be helpful.

    Yes! I am Interested

    Keytruda

    REQUEST CALLBACK

    Keytruda
    • Keytruda
    • Keytruda
    • Keytruda
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 1.8 Lakh / VialGet Latest Price

    Product Details:
    Minimum Order Quantity1 Vial
    Dose/Strength50mg,100mg
    Packaging Typeglass bottle
    BrandKeytruda
    CertificationGMP, FDA, ISO
    Dosage Forminjection
    Product Typeinjection
    Storage Conditioncool place
    Form of Medicineinjection
    UsagePersonal
    Compositionpembrolizumab
    Drug Namepembrolizumab
    Saltpembrolizumab

    1 NAME OF THE MEDICINE pembrolizumab (rch) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION KEYTRUDA® 50 mg powder for injection One vial contains 50 mg of pembrolizumab. After reconstitution, 1 mL of solution contains 25 mg of pembrolizumab. KEYTRUDA® 100 mg/4 mL concentrated injection One vial contains 100 mg of pembrolizumab in 4 mL of solution. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM KEYTRUDA® 50 mg powder for injection KEYTRUDA 50 mg powder for injection is a sterile, preservative-free, white to off-white lyophilised powder. Not for direct infusion or injection (see Section 4.2 DOSE AND METHOD OF ADMINISTRATION). KEYTRUDA® 100 mg/4 mL concentrated injection KEYTRUDA 100 mg/4 mL concentrated injection is a sterile, preservative-free, clear to slightly opalescent, colourless to slightly yellow solution. Not for direct infusion or injection (see Section 4.2 DOSE AND METHOD OF ADMINISTRATION). 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS KEYTRUDA® (pembrolizumab) is indicated as monotherapy for the treatment of unresectable or metastatic melanoma in adults. KEYTRUDA® (pembrolizumab) is indicated as monotherapy for the adjuvant treatment of patients with melanoma with lymph node involvement who have undergone complete resection. KEYTRUDA® (pembrolizumab) is indicated as monotherapy for the first-line treatment of patients with metastatic non-small cell lung carcinoma (NSCLC) whose tumours express PDL1 with a ≥50% tumour proportion score (TPS) as determined by a validated test, with no EGFR or ALK genomic tumour aberrations. KEYTRUDA® (pembrolizumab), in combination with pemetrexed and platinum chemotherapy, is indicated for the first-line treatment of patients with metastatic non- 2 squamous NSCLC, with no EGFR or ALK genomic tumour aberrations. KEYTRUDA® (pembrolizumab) is indicated as monotherapy for the treatment of patients with advanced NSCLC whose tumours express PD-L1 with a ≥1% TPS as determined by a validated test and who have received platinum-containing chemotherapy. Patients with EGFR or ALK genomic tumour aberrations should have received prior therapy for these aberrations prior to receiving KEYTRUDA. KEYTRUDA® (pembrolizumab) is indicated as monotherapy for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) with disease progression on or after platinum-containing chemotherapy. This indication is approved based on overall response rate and duration of response. Improvements in overall survival, progression-free survival or health-related quality of life have not been established. KEYTRUDA® (pembrolizumab) is indicated as monotherapy for the treatment of adult patients with relapsed or refractory classical Hodgkin Lymphoma (cHL): 1. following autologous stem cell transplant (ASCT) or 2. following at least two prior therapies when ASCT or multi-agent chemotherapy is not a treatment option. The approval of this indication is on the basis of objective response rate (ORR). See Section 5.1 PHARMACODYNAMIC PROPERTIES, Clinical Trials. KEYTRUDA® (pembrolizumab) is indicated for the treatment of adult and paediatric patients with refractory primary mediastinal B-cell lymphoma (PMBCL), or who have relapsed after 2 or more prior lines of therapy. The approval of this indication is on the basis of objective response rate (ORR) and duration of response from non-randomised studies. See Section 5.1 PHARMACODYNAMIC PROPERTIES, Clinical Trials. KEYTRUDA® (pembrolizumab) is indicated as monotherapy for the treatment of patients with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatincontaining therapy and whose tumours express PD-L1 [Combined Positive Score (CPS) ≥10] as determined by a validated test, or in patients who are not eligible for any platinumcontaining chemotherapy regardless of PD-L1 status.
    Yes! I am Interested

    Xgeva

    REQUEST CALLBACK

    Xgeva
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 26,500 / VialGet Latest Price

    Product Details:
    Minimum Order Quantity1 Vial
    Product TypeFinished Product
    Packaging TypeVial
    BrandXgeva
    UsageHospital
    Dose/Strength120mg
    CompositionDenosumab Solution

    Xgeva (denosumab) is a monoclonal antibody. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage. The Xgeva brand of denosumab is used to prevent bone fractures and other skeletal conditions in people with multiple myeloma, and in people with tumors that have spread to the bone.


    Additional Information:

  • Delivery Time: Depend on distance
  • Yes! I am Interested

    Docetaxel

    REQUEST CALLBACK

    Docetaxel
    • Docetaxel
    • Docetaxel
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 14,000 / VialGet Latest Price

    Product Details:
    Minimum Order Quantity1 Vial
    Dose/Strength20 mg or 80 mg
    Product TypeInjection
    Weight100
    Drug NameDocetaxel
    SaltDocetaxel
    Expiry Datelong

    Docetaxel (DTX), sold under the brand name Taxotere among others, is a chemotherapy medication used to treat a number of types of cancer.[1] This includes breast cancer, head and neck cancer, stomach cancer, prostate cancer and non-small-cell lung cancer.[2] It may be used by itself or along with other chemotherapy medication.[1] It is given by slow injection into a vein.[1]

    Common side effects include hair loss, low blood cell counts, numbness, shortness of breath, vomiting, and muscle pains.[1] Other severe side effects include allergic reactions and future cancers.[1] Side effects are more common in people with liver problems.[1] Use during pregnancy may harm the baby.[1] Docetaxel is in the taxane family of medications.[3] It works by disrupting the normal function of microtubules and thereby stopping cell division.[1]

    Docetaxel was patented in 1986 and approved for medical use in 1995.[4] It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.[5] Docetaxel is available as a generic medication.[1] 

    Yes! I am Interested

    Biomab Injection

    REQUEST CALLBACK

    Biomab Injection
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 45,000 / BoxGet Latest Price

    Product Details:
    Minimum Order Quantity1 Box
    BrandBiomab
    Packaging Typevial
    Usage/Applicationcancer medicine
    CompositionNimotuzumab
    Drug NameNimotuzumab
    Packaging Size4x10 ml
    Dose50mg
    CertificationISO, FDA, GMP

    About BIOMAb EGFR® What is BIOMAb EGFR?BIOMAb EGFR®, a humanized monoclonal antibody falls under a class of cancer treatment option known as targeted therapy.Targeted cancer therapies interfere with cancer cell growth and division in different ways and at various points during the development, growth, and spread of cancer. They target molecules specific to cancer cells and prevent the cancerous cells from growing, dividing and spreading uncontrollably.BIOMAb EGFR® (Nimotuzumab) is also known by the brand names Theracim, Theraloc, etc., in different countries where it is approved. BIOMAb EGFR® is currently approved for treatment of head and neck cancers in India, Cuba, Argentina, Colombia, Ivory Coast, Gabon, Ukraine, Peru, Vietnam and Sri Lanka; for glioma (pediatric and adult) in Cuba, Argentina, the Philippines, Myanmar, Mexico, Indonesia, Switzerland, Vietnam, Brazil and Ukraine; for nasopharyngeal cancer (a type of head and neck cancer) in China. It has been granted orphan drug status for Glioma in the USA and for Glioma and pancreatic cancer in Europe. A number of clinical trials are being conducted worldwide to evaluate the efficacy of this molecule in various other indications also like lung cancer, pancreatic cancer, cervical cancer etc.

    How does BIOMAb EGFR® work?BIOMAb EGFR® targets the epidermal growth factor receptor (EGFR) present on the cell surface. The binding of certain growth factors to this receptor starts a series of events that are essential for cell growth, differentiation, and survival (both normal and cancerous). In cancerous cells there is an over expression of EGFR leading to uncontrolled cell growth, proliferation, survival and creation of new blood vessels. A very high level of EGFR is seen in many solid tumors and has been associated with poor treatment outcomes. BIOMAb EGFR® binds to the site on EGFR where the growth factors are supposed to bind and thus prevents cancer cells from proliferating, making new blood vessels and evading death. BIOMAb EGFR® also helps the body''s immune system in recognizing the cancerous cells and fighting against them.

    Are there any serious side effects of BIOMAb EGFR®?Based on the experience of thousands of patients, BIOMAb EGFR® remains to be the unique monoclonal antibody of its class that has rarely exhibited any severe skin rashes till date.Studies conducted worldwide prove that BIOMAb EGFR® has a very good safety profile. In an Indian study of 92 patients with head and neck cancer, there have not been any incidences of severe skin rashes, hypomagnesaemia (low magnesium count) and other classical EGFR inhibition related side effects.
    In over 9,000 patients worldwide and over 3000 patients treated in India, there have rarely been any toxicities which are usually frequently reported with other EGFR targeting agents. The common side effects that have been observed with BIOMAb EGFR® are chills, rigors, nausea and very minor rashes.

    What makes BIOMAb EGFR® different from other cancer treatments?Efficacy without associated toxicities is an important feature which differentiates BIOMAb EGFR® from other targeted therapies against EGFR.
    The superior safety profile of BIOMAb EGFR® can be attributed to its proven unique molecular profile leading to its rapid clearance from normal cells, high tumor selectivity and specificity and its ability to enhance the antitumor effects of radiotherapy and chemotherapy.
    BIOMAb EGFR® has been seen to bind strongly to the tumor cells with high EGFR expression whereas in normal cells with low EGFR expression the binding is temporary or negligible. Unlike other EGFR inhibitors, there are negligible incidences of debilitating skin rashes, hypomagnesaemia or any other such side effects with BIOMAb EGFR® treatment
    Yes! I am Interested

    Eloxatin Oxaliplatin

    REQUEST CALLBACK

    Eloxatin Oxaliplatin
    Ask for Price

    Thanks for Contacting Us.

    Product Price :Get Latest Price

    Product Details:
    Minimum Order Quantity3 Vial
    Manufactured Bysanofi,Dr reddy,etc....
    BrandOxaliplatin
    Packaging Typevial
    Usage/ApplicationChemotherapy
    Product TypeInjection
    CompositionOxaliplatin
    Drug NameOxaliplatin
    SaltOxaliplatin
    Dose/Strength50mg,100mg
    Dosage Forminjection

    Oxaliplatin, sold under the brand name Eloxatin, is a cancer medication used to treat colorectal cancer. Often it is used together with fluorouracil and folinic acid (leucovorin) in advanced cancer. It is given by injection into a vein.

    Common side effects include numbness, feeling tired, nausea, diarrhea, and low blood cell count Other serious side effects include allergic reactions. Use in pregnancy is known to harm the baby. Oxaliplatin is in the platinum-based antineoplastic family of medications. It is believed to work by blocking the duplication of DNA.

    Oxaliplatin was patented in 1976 and approved for medical use in 1996. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is 8.74 to 125.43 USD a vial. In the United Kingdom, it costs the NHS 299.50 pounds per 100 mg dose

    Yes! I am Interested

    Gemcitabine 1000 Mg Injection

    REQUEST CALLBACK

    Gemcitabine 1000 Mg Injection
    • Gemcitabine 1000 Mg Injection
    • Gemcitabine 1000 Mg Injection
    Ask for Price

    Thanks for Contacting Us.

    Product Price :Get Latest Price

    Product Details:
    Minimum Order Quantity3 Vial
    Manufactured Byneon , lilly , natco etc....
    BrandGemcitabine
    Packaging Typeglass bottle
    Usage/Applicationbreast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer
    Product TypeInjection
    CompositionGemcitabine
    Drug NameGemcitabine
    SaltGemcitabine
    Dose/Strength200mg,1gm
    Dosage FormInjection
    Form of Medicinepowder
    Grade Standardmedicine
    Packing Materialglass
    Quantity Per Packone
    Age Groupdepend on patient
    Purity100%
    Expiry Datelong
    UsageHospital
    CertificationFDA

    Gemcitabine, sold under the brand name Gemzar, among others, is a chemotherapy medication used to treat a number of types of cancer. These cancers include breast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer. It is given by slow injection into a vein.
    Common side effects include bone marrow suppression, liver and kidney problems, nausea, fever, rash, shortness of breath, mouth sores, diarrhea, neuropathy, and hair loss. Use during pregnancy will likely result in harm to the baby. Gemcitabine is in the nucleoside analog family of medication. It works by blocking the creation of new DNA, which results in cell death.
    Gemcitabine was patented in 1983 and was approved for medical use in 1995. Generic versions were introduced in Europe in 2009 and in the US in 2010. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is about US$24.41 to $316.99 per gram vial. In the United Kingdom, a 1 g vial costs the NHS approximately £155.
    Yes! I am Interested

    Secukinumab Injection

    REQUEST CALLBACK

    Secukinumab Injection
    • Secukinumab Injection
    • Secukinumab Injection
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 18,000 / BoxGet Latest Price

    Product Details:
    Minimum Order Quantity3 Box
    Packaging Size150mg
    BrandScapho
    Age Groupany age
    CompositionSecukinumab Injection
    Dose150 mg
    Drug Strength150mg
    Forminjection
    Form of Medicineliquid
    GenderUnisex
    Grademedicine
    Injectable FormLiquid
    MaterialInjection
    Medicine TypeInjection
    Other NameSecukinumab Injection
    Packing Typebox
    Power150mg
    Product TypeFinished Product
    Shelf Life2 years
    Usage/ApplicationPersonal

    Secukinumab injection is used to treat moderate to severe plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) in people whose psoriasis is too severe to be treated by topical medications alone. Secukinumab injection is in a class of medications called monoclonal antibodies. It works by stopping the action of certain cells in the body that cause the symptoms of psoriasis.

    Secukinumab injection comes as a prefilled syringe, a dosing pen, and as a powder to be mixed with liquid and injected subcutaneously (under the skin). It is usually injected once every week for the first 5 doses and then once every 4 weeks. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use secukinumab injection exactly as directed. Do not inject more or less of it or inject it more often than prescribed by your doctor.

    You may receive your first subcutaneous dose of secukinumab injection in your doctor's office. After that, your doctor may allow you to inject secukinumab yourself or have a friend or relative perform the injections. Before you use secukinumab injection yourself the first time, read the manufacturer's information for the patient that comes with the medication. Ask your doctor or pharmacist to show you or the person who will be injecting the medication how to inject it.

    Use each syringe or dosing pen only once and inject all the solution in the syringe or pen. Dispose of used syringes and pens in a puncture-resistant container. Talk to your doctor or pharmacist about how to dispose of the puncture-resistant container.

    If you are using a prefilled syringe or a dosing pen that has been refrigerated, place the syringe or pen on a flat surface without removing the needle cap and allow it warm to room temperature for 15-30 minutes before you are ready to inject the medication. Do not try to warm the medication by heating it in a microwave, placing it in hot water, or through any other method. Use the injection at least 1 hour after taking it out of the refrigerator.

    Do not shake a syringe or dosing pen that contains secukinumab.

    Always look at secukinumab solution before injecting it. Check that the expiration date has not passed and that the liquid is clear and colorless. The liquid should not contain visible particles. Do not use a syringe or dosing pen if it is cracked or broken, if it is expired, or if the liquid is cloudy or contains large or colored particles.

    You can inject secukinumab injection anywhere on the front of your thighs (upper leg), upper outer arms, or abdomen (stomach) except your navel and the area 2 inches (5 centimeters) around it. To reduce the chances of soreness or redness, use a different site for each injection. Do not inject into an area where the skin is tender, bruised, red, or hard or where you have scars or stretch marks.

    Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with secukinumab injection. Read the information carefully and ask your doctor or pharmacist if you have any questions.

    Yes! I am Interested

    Zoldonat 4 mg injection

    REQUEST CALLBACK

    Zoldonat 4 mg injection
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 700 / PieceGet Latest Price

    Product Details:
    Minimum Order Quantity5 Piece
    Dose/Strength4mg
    Packaging Typeampule
    Product TypeInjection
    Form of Medicineluqide
    CompositionZoledronic acid
    Drug NameZoledronic acid
    SaltZoledronic acid

    Zoledronate(4 Mg)Uses
    Zoldonat 4 mg injection is used in the treatment of post menopausal osteoporosis (porous bones), osteoporosis in men (porous bones) and steroid induced osteoporosis (porous bones)How it works
    Zoledronic acid belongs to a class of drugs known as bisphosphonates.  It works by slowing bone breakdown, increasing bone density (thickness), and decreasing the amount of calcium released from the bones into the blood.
    Yes! I am Interested

    Mabthera Rituximab

    REQUEST CALLBACK

    Mabthera Rituximab
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 30,000 / VialGet Latest Price

    Product Details:
    Minimum Order Quantity3 Vial
    Dose/Strength100mg or 500mg
    Packaging Typevial
    BrandRoche
    MaterialLiquid
    Dosage Formas per prescribed
    Product TypeInjection
    Storage Conditioncool place
    CompositionRituximab
    Drug NameRituximab
    SaltRituximab
    Usage/Applicationnflammatory disease of the joints known as rheumatoid arthritis.

    Rituximab is used to treat certain types of cancer (such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia). It works by slowing or stopping the growth of cancer cells.

    Rituximab is used to treat rheumatoid arthritis and can decrease joint pain and swelling. It is also used to treat certain types of blood vessel disease (such as Wegener's granulomatosis, microscopic polyangiitis) and can decrease the swelling of the blood vessels. Rituximab is also used to treat a certain skin condition (pemphigus vulgaris). It helps to reduce the number of skin lesions.

    Yes! I am Interested

    Invanz injection

    REQUEST CALLBACK

    Invanz injection
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 3,000 / VialGet Latest Price

    Product Details:
    Minimum Order Quantity10 Vial
    Product TypeFinished Product
    Drug Strength1gm
    Form of Medicineinjection
    Injectable FormLiquid
    Packing Typeglass
    Medicine Typeantibiotic injection
    Formliquid
    CompositionErtapenem
    Grademedicine
    Power1gm
    Age Groupany
    Materialliquid
    GenderUnisex
    Usage/ApplicationPersonal

    Invanz 1 gm Injection is an antibiotic used to treat a variety of infections caused by bacteria such as infections in the stomach, pelvis, urinary tract, skin, and lungs. It should be used with caution in patients with central nervous system disorders.

    Read the Patient Information Leaflet if available from your pharmacist before you start using ertapenem and each time you get a refill. If you have any questions, ask your doctor or pharmacist.

    This medication is given by injection into a muscle or vein as directed by your doctor, usually once or twice daily. If you are using this medication to prevent an infection, it is given by injection into a vein by a health care professional. It is given as directed by your doctor, usually 1 hour before your surgery.

    If this medication is given by injection into a muscle, follow the manufacturer's directions for mixing with lidocaine 1 percent solution. Do not use this solution for injection into a vein.

    If you are using this medication at home, learn all preparation and usage instructions from your health care professional. Before using, check this product visually for particles or discoloration. If either is present, do not use the liquid. Learn how to store and discard medical supplies safely.

    The dosage is based on your medical condition and response to treatment. In children, the dosage is also based on age and weight.

    For the best effect, use this antibiotic at evenly spaced times. To help you remember, use this medication at the same time(s) every day.

    Continue to use this medication until the full prescribed treatment period is finished, even if symptoms disappear after a few days. Stopping the medication too early may result in a return of the infection.

    Tell your doctor if your condition lasts or gets worse.

    Yes! I am Interested

    Grafeel Injection

    REQUEST CALLBACK

    Grafeel Injection
    Get Best Quote

    Thanks for Contacting Us.

    Approx. Rs 1,400 / PieceGet Latest Price

    Product Details:
    Minimum Order Quantity10 Piece
    Doseas per doctor
    Product Typeinjection
    Dose/Strength300mcg
    Packaging Typeinjection
    Materialliquid
    Dosage Form300mcg
    Packing Materialplastic
    Quantity Per Pack1
    Storage Conditioncool
    GenderUnisex
    No of tabletsno
    CompositionFilgrastim
    Age Groupno
    Drug NameFilgrastim
    Purity100%
    SaltFilgrastim
    Usage/Applicationchemotherapy procedures for cancer

    Grafeel 300 mcg Injection is a human granulocyte colony-stimulating factor (G-CSF) analog. It stimulates the growth of white blood cells and helps in decreasing the chances of infection in patients who are undergoing chemotherapy procedures for cancer. Patients with blood disorders are advised not to use this medicine.
    Yes! I am Interested

     
    X


    Explore More Products

    Contact via E-mail
    Contact via SMS
    Medicine Impex
    Manoj Yadav (Proprietor)
    G- 4, Building No. 2, Summer Nagar, Sv Road , Borivali,
    Mumbai - 400092, Maharashtra, India
    Call Us: 
    Call Response Rate: 77%
    Share Us :
    F G T L



    Home  |   Who We Are   |  Our Product Range  |  Site Map  |   Contact Us

    © Medicine Impex. All Rights Reserved (Terms of Use)
    Developed and Managed by IndiaMART InterMESH Limited

    Medicine Impex